Rigorous CBD Trial for Autism Behavioral Symptoms Launches—But Results Are Not Yet In
The CASCADE CBD autism trial protocol 2024 outlines a rigorous placebo-controlled crossover study of pharmaceutical cannabidiol for irritability and aggression in children with autism spectrum disorder. This trial addresses critical gaps by using…
Cannabis Added to Standard Pain Medications Did Not Reach Clinically Meaningful Pain Relief in Brachial Plexus Injury
The cannabis brachial plexus injury pain trial found a statistically significant but clinically insufficient pain reduction. Cannabis-based medicine did not improve pain by a clinically important margin. Sleep quality improved modestly, suggesting…
Australian Trial to Test Whether Cannabis Can Prevent Chemotherapy Gut Damage: Protocol Published
The cannabis chemotherapy mucositis trial is the first rigorous study testing combined CBD and THC to prevent chemotherapy-induced gut damage. This protocol outlines the design of a phase II randomized controlled trial focused on gastrointestinal…
Brief Online Mindfulness Training Does Not Reduce Cannabis Use in Adults with Cannabis Use Disorder
A brief online mindfulness program was tested for its effect on cannabis use disorder. The study found no significant reduction in cannabis use frequency or craving. These findings highlight the challenges of brief digital mindfulness interventions for…
Research Digest: 5 Recent Studies – March 25, 2026
This research digest presents recent studies on the real-time and long-term effects of medical marijuana. The focus is on older adults and how medical marijuana impacts cognitive and physical health. These findings provide valuable insights into medical…
Exploring Cannabis and the Endocannabinoid System in Family Medicine
Endocannabinoid system research cannabis family medicine is advancing clinical understanding of cannabis use in primary care. This research highlights potential therapeutic roles and safety considerations. Family medicine practitioners benefit from…
Cannabinoid Clinical Trials for Mental & Substance Disorders
Cannabinoid clinical trials mental disorders reveal limited evidence supporting cannabinoids as primary treatments. Current data do not establish clear efficacy or safety profiles. Clinicians should interpret patient interest with caution until stronger…
Reducing Severe Breathlessness with Dronabinol in Severe COPD Patients
The dronabinol COPD breathlessness trial investigates synthetic THC's potential to alleviate severe dyspnea in advanced COPD patients. This randomized, double-blinded crossover study evaluates breathing discomfort and lung function. Results will inform…
Systematic Review: Medical Cannabis for Diabetic Peripheral Neuropathy
This systematic review evaluated medical cannabis diabetic neuropathy interventions in randomized controlled trials. Evidence shows potential pain relief benefits for diabetic peripheral neuropathy. The review highlights cautious optimism for cannabis…
The effect of hemp product consumption on blood fatty acid profiles and cardiovascular disease risk factors: results of a randomized, double-blind, crossover clinical trial.
Hemp seeds cardiovascular benefits clinical trial results reveal significant effects on blood fatty acid profiles. This randomized, double-blind, crossover study highlights hemp's impact on cardiovascular disease risk factors. Hemp seeds are rich in…